Surgical and radiosurgical treatment strategies for Cushing’s disease

[1]  V. Staartjes,et al.  Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery. , 2020, Journal of neurosurgery.

[2]  O. Dekkers,et al.  Improvement but no normalization of quality of life and cognitive functioning after treatment for Cushing's syndrome. , 2019, The Journal of clinical endocrinology and metabolism.

[3]  L. Lunsford,et al.  Outcomes After Gamma Knife Stereotactic Radiosurgery in Pediatric Patients with Cushing Disease or Acromegaly: A Multi-Institutional Study. , 2019, World neurosurgery.

[4]  I. Mendichovszky,et al.  Modern imaging of pituitary adenomas. , 2019, Best practice & research. Clinical endocrinology & metabolism.

[5]  I. Bryngelsson,et al.  The incidence of Cushing’s disease: a nationwide Swedish study , 2019, Pituitary.

[6]  A. Soto-Moreno,et al.  Surgical Outcomes and Comorbidities in Cushing Disease: 30 Years of Experience in a Referral Center. , 2019, World neurosurgery.

[7]  Nathaniel D. Sisterson,et al.  Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study. , 2019, The Lancet. Oncology.

[8]  W. Young,et al.  Radiosurgical Management of Patients With Persistent or Recurrent Cushing Disease After Prior Transsphenoidal Surgery: A Management Algorithm Based on a 25-Year Experience. , 2018, Neurosurgery.

[9]  Nathaniel D. Sisterson,et al.  Upfront Gamma Knife radiosurgery for Cushing's disease and acromegaly: a multicenter, international study. , 2019, Journal of neurosurgery.

[10]  J. Sheehan,et al.  Neurocognitive changes in pituitary adenoma patients after Gamma Knife radiosurgery. , 2018, Journal of neurosurgery.

[11]  Jie Tian,et al.  Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images , 2018, European Radiology.

[12]  J. Honegger,et al.  The experience with transsphenoidal surgery and its importance to outcomes , 2018, Pituitary.

[13]  Steven D Chang,et al.  CyberKnife Radiosurgery in the Multimodal Management of Patients with Cushing Disease. , 2018, World neurosurgery.

[14]  John Y. K. Lee,et al.  Stereotactic Radiosurgery for Cushing's Disease: Results of an International, Multicenter Study , 2017, Journal of Neurological Surgery Part B: Skull Base.

[15]  Chang Liu,et al.  Volumetric magnetic resonance imaging analysis in patients with short‐term remission of Cushing's disease , 2017, Clinical endocrinology.

[16]  N. Tanriover,et al.  Outcomes of Primary Transsphenoidal Surgery in Cushing Disease: Experience of a Tertiary Center. , 2017, World neurosurgery.

[17]  E. Oldfield.  Cushing's Disease: Lessons Learned From 1500 Cases. , 2017, Neurosurgery.

[18]  E. Oldfield,et al.  Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease , 2017, The Journal of clinical endocrinology and metabolism.

[19]  M. Molitch.  Diagnosis and Treatment of Pituitary Adenomas: A Review , 2017, JAMA.

[20]  Niki Karavitaki,et al.  Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. , 2016, The lancet. Diabetes & endocrinology.

[21]  L. Nieman,et al.  Cushing's syndrome , 2015, The Lancet.

[22]  A. Tabarin,et al.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[23]  W. Woodmansee,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: POSTOPERATIVE MANAGEMENT FOLLOWING PITUITARY SURGERY. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  A. Colao,et al.  The Treatment of Cushing's Disease. , 2015, Endocrine reviews.

[25]  P. Chanson,et al.  Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. , 2015, European journal of endocrinology.

[26]  Peter R. Luijten,et al.  High resolution pituitary gland MRI at 7.0 tesla: a clinical evaluation in Cushing’s disease , 2015, European Radiology.

[27]  L. Nieman,et al.  Comorbidities in Cushing’s disease , 2015, Pituitary.

[28]  Allen L. Ho,et al.  Cushing's disease: predicting long-term remission after surgical treatment. , 2015, Neurosurgical focus.

[29]  J. Eloy,et al.  Nelson's syndrome: a review of the clinical manifestations, pathophysiology, and treatment strategies. , 2015, Neurosurgical focus.

[30]  M. Broder,et al.  Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States , 2015, Pituitary.

[31]  A. Niemierko,et al.  Outcomes of proton therapy for patients with functional pituitary adenomas. , 2014, International journal of radiation oncology, biology, physics.

[32]  P. J. Wilson,et al.  Cushing’s disease: A single centre’s experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy , 2014, Journal of Clinical Neuroscience.

[33]  E. Laws,et al.  Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission. , 2013, Neurosurgery.

[34]  M. Dally,et al.  Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience , 2012, Internal medicine journal.

[35]  P. Vestergaard,et al.  Mortality in Cushing's syndrome: a systematic review and meta-analysis. , 2012, European journal of internal medicine.

[36]  A. Vortmeyer,et al.  Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease. , 2012, Journal of neurosurgery.

[37]  Wiebke Arlt,et al.  Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. , 2012, The Journal of clinical endocrinology and metabolism.

[38]  Ferdinand Roelfsema,et al.  Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis , 2011, Pituitary.

[39]  A. Klibanski,et al.  Delayed remission after transsphenoidal surgery in patients with Cushing's disease. , 2010, The Journal of clinical endocrinology and metabolism.

[40]  P. Chanson,et al.  Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. , 2009, The Journal of clinical endocrinology and metabolism.

[41]  M. Aghi.  Management of recurrent and refractory Cushing disease , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[42]  E. Laws,et al.  OUTCOMES AFTER REPEAT TRANSSPHENOIDAL SURGERY FOR RECURRENT CUSHING'S DISEASE , 2008, Neurosurgery.

[43]  R. Fahlbusch,et al.  Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. , 2008, Journal of neurosurgery.

[44]  M. Fleseriu,et al.  Treatment options for Cushing disease after unsuccessful transsphenoidal surgery. , 2007, Neurosurgical focus.

[45]  V. Sturm,et al.  Linear accelerator radiosurgery for pituitary macroadenomas , 2006, Cancer.

[46]  J. Bertherat,et al.  Cushing ’ s syndrome , 2003 .

[47]  R. Reznek,et al.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. , 2006, The Journal of clinical endocrinology and metabolism.

[48]  A. Cmelak,et al.  The Efficacy of Linear Accelerator Radiosurgery in the Management of Patients with Cushing’s Disease , 2005, Stereotactic and Functional Neurosurgery.

[49]  Charles B. Wilson,et al.  Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. , 2004, The Journal of clinical endocrinology and metabolism.

[50]  P. Chanson,et al.  Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. , 2004, The Journal of clinical endocrinology and metabolism.

[51]  D. Lüdecke,et al.  Cushing's disease: a surgical view; This Publication is dedicated to our professor emeritus Dr. med. Rudolf Kautzky , 2001, Journal of Neuro-Oncology.

[52]  A. Tabarin,et al.  Occult Cushing's syndrome in type-2 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.

[53]  A. Klibanski,et al.  Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. , 2003, The Journal of clinical endocrinology and metabolism.

[54]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[55]  Zbigniew Petrovich,et al.  Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery , 2002 .

[56]  Y. Mori,et al.  Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. , 2002, Journal of neurosurgery.

[57]  E. Laws,et al.  The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. , 2002, Journal of neurosurgery.

[58]  C Hagen,et al.  Incidence and late prognosis of cushing's syndrome: a population-based study. , 2001, The Journal of clinical endocrinology and metabolism.

[59]  L. Brunereau,et al.  Cavernous sinus invasion by pituitary adenoma: MR imaging. , 2000, Radiology.

[60]  A. Ragin,et al.  Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. , 1997, Neurosurgery.

[61]  E. Cerasi,et al.  Pre‐clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients , 1996, Clinical endocrinology.

[62]  H. Cushing.  The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. , 1994, Obesity research.

[63]  C. Matula,et al.  Pituitary Adenomas with Invasion of the Cavernous Sinus Space , 1993 .

[64]  C. Matula,et al.  Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.

[65]  B. Scheithauer,et al.  The occurrence of dural invasion in pituitary adenomas. , 1986, Journal of neurosurgery.

[66]  R. Scott,et al.  Long-Term Results , 2001 .

[67]  J. Hardy.  Transphenoidal microsurgery of the normal and pathological pituitary. , 1969, Clinical neurosurgery.

[68]  H. Cushing.  The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism) , 1964 .